MCCP
DNA icon

Mission Creek Capital Partners’s Ginkgo Bioworks DNA Stock Holding History

Mission Creek Capital Partners’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12,915
Closed -$2.08M – 217
2022
Q1 		$2.08M Buy
+12,915
New +$2.51M 0.56% 58

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Mission Creek Capital Partners's DNA Position: Q2 2022 in Review

Mission Creek Capital Partners sold out of Ginkgo Bioworks (DNA) in Q2 2022, closing a stake of 12,915 shares — an estimated $2.08M sold.

Mission Creek Capital Partners first reported a position in DNA in Q1 2022 and held it in 1 quarter. The position peaked at $2.08M in Q1 2022. 260 funds tracked by Wall St. Rank hold DNA as of Q2 2022.

  • Mission Creek Capital Partners reported no remaining Ginkgo Bioworks position as of Q2 2022 after selling out during the quarter.
  • Mission Creek Capital Partners sold 12,915 Ginkgo Bioworks shares in Q2 2022, an estimated $2.08M.
  • Mission Creek Capital Partners first reported a position in Ginkgo Bioworks in Q1 2022 and held it in 1 quarter.
  • Mission Creek Capital Partners's Ginkgo Bioworks position peaked at $2.08M in Q1 2022.
  • 260 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2022.

Based on Mission Creek Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.